|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
Avenue Therapeutics, Inc. (ATXI) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14
|
|
Download |
|
|
Company
Roster
|
Total
Insiders : |
14 |
|
|
Total
Direct Shares :
|
6,093,853 |
|
Total
Indirect Shares :
|
330,000 |
|
%
Held by Insiders:
|
36.38% |
|
|
|
Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Weiss Michael S |
Director |
2018-08-07 |
24,663 |
|
0 |
Reines Scott |
Interim Chief Medical Officer |
2018-08-07 |
45,000 |
|
0 |
Samad Akhtar |
Director |
2018-08-07 |
64,663 |
|
0 |
Paley Jeffrey |
Director |
2018-12-10 |
79,663 |
|
0 |
Vazzano Joseph Walter |
Chief Financial Officer |
2021-12-17 |
165,757 |
|
0 |
Kranzler Jay D |
Director |
2021-12-17 |
133,683 |
|
0 |
Lu Lucy |
President, CEO, Director |
2021-12-17 |
748,949 |
|
0 |
Herskowitz Neil |
Director |
2021-12-17 |
183,744 |
|
0 |
Rosenwald Lindsay A Md |
Director |
2023-09-08 |
354,318 |
|
0 |
Coronado Biosciences Inc |
10% Owner |
2024-04-16 |
3,547,393 |
|
0 |
Invagen Pharmaceuticals, Inc. |
10% Owner |
2022-10-11 |
0 |
2019-02-08 |
250,000 |
Ingram Elizabeth Garrett |
Director |
2019-09-12 |
16,000 |
2019-09-12 |
0 |
Oltmans Curtis Gale |
Director |
2021-12-17 |
49,020 |
2021-12-17 |
0 |
Davidow Robert L |
10% Owner |
2023-12-11 |
681,000 |
2023-12-11 |
80,000 |
|
|